Editorial: Alternative Therapeutics Against Antimicrobial-Resistant Pathogens.
Rebecca Thombre, Kamlesh Jangid, Ravi Shukla, Noton Kumar Dutta
Author Information
- Rebecca Thombre: Department of Biotechnology, Modern College of Arts, Science and Commerce, Pune, India.
- Kamlesh Jangid: National Centre for Microbial Resource, National Centre for Cell Science, Savitribai Phule Pune University Campus, Pune, India.
- Ravi Shukla: NanoBiotechnology Research Laboratory, RMIT University, Melbourne, VIC, Australia.
- Noton Kumar Dutta: Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
No abstract text available.
- J Antimicrob Chemother. 2016 Jun;71(6):1570-7
[PMID: 26903278]
- Antimicrob Agents Chemother. 2014 Jul;58(7):4048-53
[PMID: 24798290]
- Front Microbiol. 2010 Dec 08;1:134
[PMID: 21687759]
- Int J Antimicrob Agents. 2010 Oct;36(4):295-302
[PMID: 20591629]
- J Infect Dis. 2019 Apr 19;219(10):1518-1524
[PMID: 30590592]
- FEMS Microbiol Rev. 2018 Nov 1;42(6):781-804
[PMID: 30085063]
- PLoS One. 2010 Apr 08;5(4):e10069
[PMID: 20386700]
- Eur J Clin Microbiol Infect Dis. 2009 Aug;28(8):881-91
[PMID: 19399540]
- Front Microbiol. 2016 Sep 13;7:1424
[PMID: 27679615]
- Int J Antimicrob Agents. 2007 Sep;30(3):242-9
[PMID: 17644318]